Bogdan Zagribelnyy

Bogdan Zagribelnyy is a Senior Researcher in Medicinal Chemistry and Computer-Aided Drug Design (CADD) at Insilico Medicine, where responsibilities include the design and validation of the Chemistry42 AI-platform for automated drug discovery and leadership of the SARS-CoV-2 3CLpro inhibitor project. Additionally, Bogdan serves as a Lecturer in Medicinal Chemistry at Lomonosov Moscow State University, where a Master of Science in Organic, Medicinal, and Pharmaceutical Chemistry was attained from 2013 to 2019.